Changing the deferral for men who have sex with men – an improved model to estimate HIV residual risk
Authors:
- Katy L. DavisonKDKaty L. Davison
- Yves GregoireYGYves Gregoire
- Brian CusterBCBrian Custer
- Clive R. SeedCSClive R. Seed
- On behalf of the Surveillance, Risk Assessment, Policy Sub-Group of the ISBT Transfusion Transmitted Diseases Working PartyOPOn behalf of the Surveillance, Risk Assessment, Policy Sub-Group of the ISBT Transfusion Transmitted Diseases Working Party
- 1 August 2019
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 114 (7) , 666-674
Abstract
Background and Objectives Eight published studies modelled the impact of changing from a lifetime to time-limited deferral for men who have sex with men (MSM); each predicted greater risk impact than has been observed. This study uses these previous efforts to develop an ‘optimized’ model to inform future changes to MSM deferrals. Materials and Methods HIV residual risk was calculated using observed HIV incidence/prevalence prior to the change in MSM deferral, then with the additional MSM expected under a 12-month deferral for five compliance scenarios, and finally using data observed after implementation of the deferral. Monte Carlo simulation calculated 95% confidence intervals (CI). Results The architecture of reviewed models was sound, and two were selected for combination into the optimized model. HIV risk estimated by this in the UK under MSM lifetime deferral was 0·102 (95% CI: 0·050–0·172) per million. The model predicted from a 27·8% decrease to a 47·6% increase depending upon compliance pre-implementation of the 12-month deferral. A decrease of 0·9% was observed post-implementation. For Canada, HIV risk under a 5-year deferral was 0·050 (95% CI: 0·00003–0·122) per million. Pre-implementation of the 12-month deferral, the model predicted from 30·2% decrease to 10-fold increase. A decrease of 47·0% was observed after implementation. Conclusion The optimized model predicted HIV risk under 12-month MSM deferral in UK and Canada would remain low, and this was confirmed post-implementation. While the model is adaptable to other deferral scenarios, improved data quality would improve precision, particularly estimates of incidence in individuals likely to donate.Keywords
This publication has 27 references indexed in Scilit:
- Compliance with the current 12‐month deferral for male‐to‐male sex in AustraliaVox Sanguinis, 2013
- SaBTO review of blood donor selection criteria related to sexual behaviourTransfusion Medicine, 2011
- International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009Vox Sanguinis, 2011
- Deferral from donating blood of men who have sex with men: impact on the risk of HIV transmission by transfusion in FranceVox Sanguinis, 2011
- A re‐evaluation of the risk of transfusion‐transmitted HIV prevented by the exclusion of men who have sex with men from blood donation in England and Wales, 2005–2007Vox Sanguinis, 2011
- Relative Risk of Reducing the Lifetime Blood Donation Deferral for Men Who Have Had Sex With Men Versus Currently Tolerated Transfusion RisksTransfusion Medicine Reviews, 2011
- No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME)Transfusion, 2010
- Insights into the rise in HIV infections, 2001 to 2008: a Bayesian synthesis of prevalence evidenceAIDS, 2010
- Reconsidering the lifetime deferral of blood donation by men who have sex with menCanadian Medical Association Journal, 2010
- Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with menTransfusion, 2009